CLINICAL TRIALS PROFILE FOR FENOGLIDE
✉ Email this page to a colleague
All Clinical Trials for Fenoglide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02158273 ↗ | Medication Development in Alcoholism: Investigating PPAR Agonists | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 | 2014-05-01 | The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo. |
NCT02158273 ↗ | Medication Development in Alcoholism: Investigating PPAR Agonists | Completed | The Scripps Research Institute | Phase 2 | 2014-05-01 | The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Fenoglide
Condition Name
Clinical Trial Locations for Fenoglide
Trials by Country
Clinical Trial Progress for Fenoglide
Clinical Trial Phase
Clinical Trial Sponsors for Fenoglide
Sponsor Name